June 21, 2019
Recent FDA Inspection of KCAS Bioanalytical & Biomarker Services’ Kansas City, KS Facility is Successful with No 483s issued
Kansas-based KCAS, a leading bioanalytical testing laboratory for the Pharmaceutical, Biopharmaceutical, Animal Health and Medical Device industries, said that its Shawnee Mission site, a bioanalytical testing laboratory facility, successfully completed a U.S. Food and Drug Administration (FDA) general re-inspection conducted between June 10 and June 13, 2019. The previous inspection of KCAS took place in 2016.